RELEASE OF 5-AMINOSALICYLIC ACID FROM PENTASA DURING NORMAL AND ACCELERATED INTESTINAL TRANSIT-TIME

被引：29
|
作者：
CHRISTENSEN, LA
SLOT, O
SANCHEZ, G
BOSERUP, J
RASMUSSEN, SN
BONDESEN, S
HANSEN, SH
HVIDBERG, EF
机构：
[1] UNIV COPENHAGEN,RIGSHOSP,DEPT CLIN PHARMACOL 3124,9 BLEGDAMSVEJ,DK-2100 COPENHAGEN O,DENMARK
[2] AALBORG HOSP,DEPT MED GASTROENTEROL,DK-9000 AALBORG,DENMARK
[3] ROYAL DANISH SCH PHARM,DEPT ORGAN CHEM,DK-2100 COPENHAGEN O,DENMARK
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 23卷 / 03期
关键词：
D O I：
10.1111/j.1365-2125.1987.tb03061.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：365 / 369
页数：5
相关论文
共 50 条
  • [1] DISPOSITION OF 5-AMINOSALICYLIC ACID FROM 5-AMINOSALICYLIC ACID-DELIVERING DRUGS DURING ACCELERATED INTESTINAL TRANSIT IN HEALTHY-VOLUNTEERS
    RIJK, MCM
    VANHOGEZAND, RA
    VANSCHAIK, A
    VANTONGEREN, JHM
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1989, 24 (10) : 1179 - 1185
  • [2] THE INFLUENCE OF INTESTINAL TRANSIT-TIME ON 5-ASA FROM PENTASA
    CHRISTENSEN, LA
    SANCHEZ, G
    RASMUSSEN, SN
    SLOT, O
    BOSERUP, J
    BONDESEN, S
    HANSEN, SH
    HVIDBERG, EF
    GASTROENTEROLOGY, 1986, 90 (05) : 1373 - 1373
  • [3] OROILEAL TRANSIT OF SLOW-RELEASE 5-AMINOSALICYLIC ACID
    GOEBELL, H
    KLOTZ, U
    NEHLSEN, B
    LAYER, P
    GUT, 1993, 34 (05) : 669 - 675
  • [4] BIOAVAILABILITY OF 5-AMINOSALICYLIC ACID FROM SLOW-RELEASE 5-AMINOSALICYLIC ACID DRUG AND SULFASALAZINE IN NORMAL-CHILDREN
    CHRISTENSEN, LA
    FALLINGBORG, J
    JACOBSEN, BA
    ABILDGAARD, K
    RASMUSSEN, HH
    RASMUSSEN, SN
    HANSEN, SH
    DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (10) : 1831 - 1836
  • [5] OROILEAL TRANSIT OF 5-AMINOSALICYLIC ACID
    CHRISTENSEN, LA
    FALLINGBORG, J
    GUT, 1994, 35 (02) : 287 - 287
  • [6] 5-AMINOSALICYLIC ACID (PENTASA) IN THE MAINTENANCE OF REMISSION OF CROHNS-DISEASE
    SUTHERLAND, LR
    MARTIN, F
    BAILEY, RJ
    FEDORAK, R
    DALLAIRE, C
    ROSSMAN, R
    POLESKI, M
    HARVEY, W
    LARIVIERE, L
    GASTROENTEROLOGY, 1995, 108 (04) : A924 - A924
  • [7] 5-aminosalicylic acid release from a new controlled-release mesalazine formulation during gastrointestinal transit in healthy volunteers
    Brunner, M
    Lackner, E
    Exler, PS
    De Fluiter, HC
    Kletter, K
    Tschurlovits, M
    Dudczak, R
    Eichler, HG
    Müller, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (01) : 137 - 144
  • [8] Release kinetics of 5-aminosalicylic acid from halloysite
    Aguzzi, C.
    Viseras, C.
    Cerezo, P.
    Salcedo, I.
    Sanchez-Espejo, R.
    Valenzuela, C.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2013, 105 : 75 - 80
  • [9] 5-AMINOSALICYLIC ACID IN PATIENTS WITH AN ILEORECTAL ANASTOMOSIS - A COMPARISON OF THE FATE OF SULFASALAZINE AND PENTASA
    BONDESEN, S
    TAGEJENSEN, U
    JACOBSEN, O
    HANSEN, SH
    RASMUSSEN, SN
    HVIDBERG, EF
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (01) : 23 - 26
  • [10] Combination therapy with 5-aminosalicylic acid and azathioprine compared with 5-aminosalicylic acid monotherapy for intestinal Behcet's disease
    Kim, Joo Sung
    Kim, Jihye
    Chun, Jaeyoung
    Park, Youn Su
    Kwon, Jee Hye
    Kim, Jee Hyun
    Lee, Jooyoung
    Im, Jong Pil
    Cheon, Jae Hee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 106 - 106
12345